LibraGen

LibraGen is a French biotechnology company specializing in the discovery, development, and production of enzymes and bioactive compounds through metagenomics and biocatalysis. Founded in 2001 and now a part of the Seqens group, the company provides specialized CRO and CDMO services to the pharmaceutical, cosmetic, and fine chemical industries. Their core expertise lies in metabolic engineering and the optimization of biosynthetic pathways to create sustainable and efficient chemical processes. LibraGen leverages a vast library of microbial resources to identify novel biocatalysts for complex chemical transformations. The company's platform enables the transition from traditional chemical synthesis to greener, enzyme-based manufacturing.